Literature DB >> 33531504

Nucleic acid binding by SAMHD1 contributes to the antiretroviral activity and is enhanced by the GpsN modification.

Akash Bhattacharya1, Mirjana Persaud2, Corey H Yu1, Alexander B Taylor1, Zhonghua Wang1, Angel Bulnes-Ramos2, Joella Xu3, Anastasia Selyutina2, Alicia Martinez-Lopez2, Kristin Cano1, Borries Demeler4,5, Baek Kim3, Stephen C Hardies1, Felipe Diaz-Griffero6, Dmitri N Ivanov7.   

Abstract

SAMHD1 impedes infection of myeloid cells and resting T lymphocytes by retroviruses, and the enzymatic activity of the protein-dephosphorylation of deoxynucleotide triphosphates (dNTPs)-implicates enzymatic dNTP depletion in innate antiviral immunity. Here we show that the allosteric binding sites of the enzyme are plastic and can accommodate oligonucleotides in place of the allosteric activators, GTP and dNTP. SAMHD1 displays a preference for oligonucleotides containing phosphorothioate bonds in the Rp configuration located 3' to G nucleotides (GpsN), the modification pattern that occurs in a mechanism of antiviral defense in prokaryotes. In the presence of GTP and dNTPs, binding of GpsN-containing oligonucleotides promotes formation of a distinct tetramer with mixed occupancy of the allosteric sites. Mutations that impair formation of the mixed-occupancy complex abolish the antiretroviral activity of SAMHD1, but not its ability to deplete dNTPs. The findings link nucleic acid binding to the antiretroviral activity of SAMHD1, shed light on the immunomodulatory effects of synthetic phosphorothioated oligonucleotides and raise questions about the role of nucleic acid phosphorothioation in human innate immunity.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33531504      PMCID: PMC7854603          DOI: 10.1038/s41467-021-21023-8

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  92 in total

1.  Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion.

Authors:  Yong Chan Kim; Ravikiran Bhairavabhotla; Jeongheon Yoon; Amit Golding; Angela M Thornton; Dat Q Tran; Ethan M Shevach
Journal:  Blood       Date:  2012-01-31       Impact factor: 22.113

2.  SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4+ T Cells.

Authors:  Jenna M Antonucci; Sun Hee Kim; Corine St Gelais; Serena Bonifati; Tai-Wei Li; Olga Buzovetsky; Kirsten M Knecht; Alice A Duchon; Yong Xiong; Karin Musier-Forsyth; Li Wu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

3.  The Timetree of Prokaryotes: New Insights into Their Evolution and Speciation.

Authors:  Julie Marin; Fabia U Battistuzzi; Anais C Brown; S Blair Hedges
Journal:  Mol Biol Evol       Date:  2017-02-01       Impact factor: 16.240

4.  SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.

Authors:  Adriana Goncalves; Evren Karayel; Gillian I Rice; Keiryn L Bennett; Yanick J Crow; Giulio Superti-Furga; Tilmann Bürckstümmer
Journal:  Hum Mutat       Date:  2012-04-16       Impact factor: 4.878

5.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Anh Nguyen; Baek Kim; Marina Tuzova; Felipe Diaz-Griffero
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

6.  A unique deoxyguanosine triphosphatase is responsible for the optA1 phenotype of Escherichia coli.

Authors:  B B Beauchamp; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

8.  SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells.

Authors:  Caroline Goujon; Lise Rivière; Loraine Jarrosson-Wuilleme; Jeanine Bernaud; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  Retrovirology       Date:  2007-01-09       Impact factor: 4.602

9.  Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9.

Authors:  Jelka Pohar; Duško Lainšček; Ana Kunšek; Miša-Mojca Cajnko; Roman Jerala; Mojca Benčina
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

10.  Mechanism of allosteric activation of SAMHD1 by dGTP.

Authors:  Xiaoyun Ji; Ying Wu; Junpeng Yan; Jennifer Mehrens; Haitao Yang; Maria DeLucia; Caili Hao; Angela M Gronenborn; Jacek Skowronski; Jinwoo Ahn; Yong Xiong
Journal:  Nat Struct Mol Biol       Date:  2013-10-20       Impact factor: 15.369

View more
  3 in total

1.  Phosphorylation of SAMHD1 Thr592 increases C-terminal domain dynamics, tetramer dissociation and ssDNA binding kinetics.

Authors:  Benjamin Orris; Kevin W Huynh; Mark Ammirati; Seungil Han; Ben Bolaños; Jason Carmody; Matthew D Petroski; Benedikt Bosbach; David J Shields; James T Stivers
Journal:  Nucleic Acids Res       Date:  2022-07-22       Impact factor: 19.160

2.  Mechanism by which T7 bacteriophage protein Gp1.2 inhibits Escherichia coli dGTPase.

Authors:  Bradley P Klemm; Deepa Singh; Cassandra E Smith; Allen L Hsu; Lucas B Dillard; Juno M Krahn; Robert E London; Geoffrey A Mueller; Mario J Borgnia; Roel M Schaaper
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-06       Impact factor: 12.779

Review 3.  Mechanistic Interplay between HIV-1 Reverse Transcriptase Enzyme Kinetics and Host SAMHD1 Protein: Viral Myeloid-Cell Tropism and Genomic Mutagenesis.

Authors:  Nicole E Bowen; Adrian Oo; Baek Kim
Journal:  Viruses       Date:  2022-07-26       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.